semaglutide and contrave vs. Wegovy - Difference in Weight Loss, Side Effects & Dosage Contrave vs Wegovy: Best Weight
Description
Please enable JavaScript or switch to a supported browser to continue using x.com
18, 2024 Management skills needed Effective management of patients receiving GLP-1 therapy is key to mitigating a well-known problem: side effects that prompt many patients to discontinue GLP-1 drugs before they achieve the full benefits
Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022)
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
Common gastrointestinal side effects include: Nausea (1222% of patients, dose-dependent) Diarrhea (1316% of patients) Vomiting (69% of patients) Constipation (67% of patients) Abdominal pain or discomfort (69% of patients) Decreased appetite (59% of patients) These effects are generally mild to moderate in severity and most pronounced during dose escalation
Yabut JM, Drucker DJ (2023) Glucagon-like peptide-1 receptor-based therapeutics for metabolic liver disease
GLP-1 medications arent cheap
